Literature DB >> 11380834

Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.

A F Perna1, P Castaldo, N G De Santo, E di Carlo, A Cimmino, P Galletti, V Zappia, D Ingrosso.   

Abstract

BACKGROUND: Several alterations of protein structure and function have been reported in uremia. Impairment of a transmethylation-dependent protein repair mechanism possibly related to a derangement in homocysteine metabolism is also present in this condition, causing erythrocyte membrane protein damage. Homocysteine may affect proteins via the accumulation of its parent compound S-adenosylhomocysteine (AdoHcy), a powerful in vivo methyltransferase inhibitor. However, since plasma homocysteine is mostly protein bound, a direct influence on protein structures cannot be ruled out. We measured the levels of L-isoaspartyl residues in plasma proteins of uremic patients on hemodialysis. These damaged residues are markers of molecular age, which accumulate when transmethylation-dependent protein repair is inhibited and/or protein instability is increased.
METHODS: L-isoaspartyl residues in plasma proteins were quantitated using human recombinant protein carboxyl methyl transferase (PCMT). Plasma concentrations of homocysteine metabolites were also measured under different experimental conditions in hemodialysis patients.
RESULTS: The concentration of damaged plasma proteins was increased almost twofold compared to control (controls 147.83 +/- 17.75, uremics 282.80 +/- 26.40 pmol of incorporated methyl groups/mg protein, P < 0.003). The major protein involved comigrated with serum albumin. Although hyperhomocysteinemia caused a redistribution of thiols bound to plasma proteins, this mechanism did not significantly contribute to the increase in isoaspartyl residues. The S-adenosylmethionine (AdoMet)/AdoHcy concentration ratio, an indicator of the flux of methyl group transfer, was altered. This ratio was partially corrected by folate treatment (0.385 +/- 0.046 vs. 0.682 +/- 0.115, P < 0.01), but protein L-isoaspartate content was not.
CONCLUSIONS: Plasma protein damage, as determined by protein L-isoaspartyl content, is increased in uremia. This alteration is to be ascribed to an increased protein structural instability, rather than the effect of hyperhomocysteinemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380834     DOI: 10.1046/j.1523-1755.2001.00747.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

Review 1.  The role of the intestinal microbiota in uremic solute accumulation: a focus on sulfur compounds.

Authors:  Alessandra F Perna; Griet Glorieux; Miriam Zacchia; Francesco Trepiccione; Giovanna Capolongo; Carmela Vigorito; Evgeniya Anishchenko; Diego Ingrosso
Journal:  J Nephrol       Date:  2019-01-23       Impact factor: 3.902

2.  Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC.

Authors:  Rita Castro; Isabel Rivera; Carla Martins; Eduard A Struys; Erwin E W Jansen; Nuno Clode; Luís M Graça; Henk J Blom; Cornelis Jakobs; Isabel Tavares de Almeida
Journal:  J Mol Med (Berl)       Date:  2005-06-23       Impact factor: 4.599

3.  Relationship of impairment induced by intracellular S-adenosylhomocysteine accumulation with DNA methylation in human umbilical vein endothelial cells treated with 3-deazaadenosine.

Authors:  Xiaoping Yu; Wenhua Ling; Mantian Mi
Journal:  Int J Exp Pathol       Date:  2009-12       Impact factor: 1.925

4.  Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.

Authors:  Daniela De Stefano; Valeria R Villella; Speranza Esposito; Antonella Tosco; Angela Sepe; Fabiola De Gregorio; Laura Salvadori; Rosa Grassia; Carlo A Leone; Giuseppe De Rosa; Maria C Maiuri; Massimo Pettoello-Mantovani; Stefano Guido; Anna Bossi; Anna Zolin; Andrea Venerando; Lorenzo A Pinna; Anil Mehta; Gianni Bona; Guido Kroemer; Luigi Maiuri; Valeria Raia
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.